Cancer, Innovation, Bioengineering, Nanoparticles, Stanford Scope.
carry cancer-fighting medicines directly to tumors, while minimizing the potential side-effects on healthy cells. Bryan Smith, PhD, director of the Translational Nanomedicine laboratory in the Radiology and Molecular Imaging Program at Stanford, and Eric Shaqfeh, PhD, professor of chemical